Isis raises $201.3M in notes offering

Isis Pharmaceuticals Inc. (NASDAQ:ISIS) raised $201.3 million through the sale of 2.75% senior unsecured convertible notes due Oct. 1, 2019, to institutional investors, including the exercise of the deal's overallotment. The notes have an initial conversion price of $16.63, which is a 26% premium to Isis' close of $13.19 on Monday, before the offering was announced. The company plans to use part of the proceeds to repay 2.625% convertible subordinated notes due 2027. Goldman Sachs and JPMorgan were co-bookrunners. ...